cephalosporin c has been researched along with Co-infection in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cain, AK; Dawson, CJ; Dinh, H; Hassan, KA; Liu, Q; Lott, H; Maharjan, R; Paulsen, IT; Penesyan, A; Semenec, L; Short, FL | 1 |
| Han, X; Hu, H; Jiang, Y; Liao, W; Meng, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhao, D; Zhou, J | 1 |
| Duployez, C; Loiez, C; Migaud, H; Senneville, E; Wallet, F | 1 |
| Alsultan, M; Ishaqui, AA; Khan, AH; Khan, I; Syed Sulaiman, SA | 1 |
| Cha, SY; Jang, HK; Kang, M; Shang, K; Wei, B; Zhang, JF | 1 |
| Fratoni, AJ; Kuti, JL; Nicolau, DP | 1 |
| Haldar, J; Maiti, PK; Mukherjee, P; Mukhopadhyay, S | 1 |
| Barbuddhe, SB; Bera, BC; Bhoyar, S; Chaudhari, SP; Choudhary, BK; Choudhary, M; Jain, A; Kale, SB | 1 |
| Campisciano, G; Colli, C; Comar, M; Corich, L; De Seta, F; Favero, B; Monasta, L; Petix, V; Zanotta, N | 1 |
| Arvai, M; Kárpáti, S; Marschalkó, M; Mihalik, N; Ostorházi, E | 1 |
| Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Coetzee, JF; Day, DN; Ellingson, J; Gehring, R; Karriker, LA; Kinyon, JM; Sparks, JW; Stalder, KJ; Stock, ML; Wang, C; Wulf, LW; Zhang, J | 1 |
| Agga, GE; Arthur, TM; Schmidt, JW | 1 |
| Adderson, EE; Flynn, PM; Frediani, J; Herr, M; Hoffman, JM | 1 |
15 other study(ies) available for cephalosporin c and Co-infection
| Article | Year |
|---|---|
Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cephalosporins; Coinfection; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Investigating Possible Interspecies Communication of Plasmids Associated with Transfer of Third-Generation Cephalosporin, Quinolone, and Colistin Resistance Between Simultaneously Isolated Escherichia Coli and Klebsiella Pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Coinfection; Colistin; Communication; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2023 |
Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Coinfection; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections | 2020 |
Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.
Topics: Antiviral Agents; Bacterial Infections; Cephalosporins; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir | 2020 |
Genetic diversity of extended-spectrum cephalosporin resistance in Salmonella enterica and E. coli isolates in a single broiler chicken.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Chickens; Coinfection; Escherichia coli; Farms; Genetic Variation; Plasmids; Salmonella enterica | 2021 |
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Coinfection; Continuous Renal Replacement Therapy; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia; Stenotrophomonas maltophilia | 2021 |
Isolation of bacteria from diabetic foot ulcers with special reference to anaerobe isolation by simple two-step combustion technique in candle jar.
Topics: Bacteria, Anaerobic; Cephalosporins; Coinfection; Diabetic Foot; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 2017 |
Isolation and characterization of multidrug-resistant Leclercia species from animal clinical case.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Coinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Animal; Immunocompromised Host; India | 2018 |
Topics: Adult; Alleles; Anti-Bacterial Agents; Cephalosporins; Chlamydia trachomatis; Ciprofloxacin; Coinfection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Genotype; Humans; Italy; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Pilot Projects; Young Adult | 2019 |
[Purulent keratoconjunctivitis due to Neisseria gonorrhoeae and Chlamydia trachomatis coinfection].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Chlamydia trachomatis; Coinfection; Conjunctivitis, Bacterial; Conjunctivitis, Inclusion; Homosexuality, Male; Humans; Injections, Intravenous; Male; Neisseria gonorrhoeae; Polymerase Chain Reaction; Sex Offenses; Sexual Behavior; Staphylococcus aureus | 2013 |
In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteroides fragilis; Ceftaroline; Cephalosporins; Coinfection; Drug Administration Schedule; Drug Combinations; Enterobacter cloacae; Escherichia coli; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome | 2013 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Coinfection; Female; Injections, Intramuscular; Porcine Reproductive and Respiratory Syndrome; Porcine respiratory and reproductive syndrome virus; Streptococcal Infections; Streptococcus suis; Swine; Swine Diseases | 2015 |
Antimicrobial-Resistant Fecal Bacteria from Ceftiofur-Treated and Nonantimicrobial-Treated Comingled Beef Cows at a Cow-Calf Operation.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Coinfection; Cross-Sectional Studies; Enterococcus; Escherichia coli; Escherichia coli Infections; Feces; Female; Gene Expression; Genes, Bacterial; Gram-Positive Bacterial Infections; Nebraska; Salmonella enterica; Salmonella Infections, Animal | 2016 |
The safety of cefepime and ceftazidime in pediatric oncology patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Coinfection; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms; Retrospective Studies; Treatment Failure; Treatment Outcome; Young Adult | 2013 |